Gijang Hospital in Busan has implemented Daewoong Pharmaceutical's AI-powered bedside monitoring system, thynC, to enhance patient safety and modernize healthcare infrastructure.
This initiative is part of a broader effort to tackle the challenges posed by limited healthcare resources in Gijang County, which has been identified as a medically underserved area. The introduction of thynC aims to integrate digital healthcare technologies into clinical practice, thereby improving accessibility and safety for patients.
The system has been installed in 50 of the hospital's 154 inpatient beds as a first step. It enables continuous real-time monitoring of patients' vital signs and provides alerts to healthcare professionals when abnormalities arise. This is especially crucial in wards where staff presence may be limited, such as during night shifts, allowing for timely interventions in case of safety incidents.
Gijang Hospital, celebrating its 29th anniversary, sees this smart ward initiative as a pivotal move towards facility renovations and comprehensive healthcare reforms. According to Dr. Heo Sung-geun, the hospital's president, the primary focus is on patient safety, and the adoption of thynC is a significant step in ensuring that local residents receive reliable inpatient care. The hospital aims to leverage this technology to not only improve patient outcomes but also to foster trust within the community.
This deployment underscores the potential of AI in addressing workforce shortages and enhancing the quality of care in regional healthcare settings. As digital transformation continues, it may serve as a model for other institutions facing similar challenges.